LCM
SRNE
Lattice Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,800
| Closed | -$26 | – | 29 |
|
|
2024
Q4 | $26 | Hold |
51,800
| – | – | ﹤0.01% | 28 |
|
|
2024
Q3 | $207 | Hold |
51,800
| – | – | ﹤0.01% | 27 |
|
|
2024
Q2 | $492 | Hold |
51,800
| – | – | ﹤0.01% | 30 |
|
|
2024
Q1 | $414 | Hold |
51,800
| – | – | ﹤0.01% | 20 |
|
|
2023
Q4 | $6.4K | Buy |
+51,800
| New | +$6.4K | ﹤0.01% | 23 |
|
|
2023
Q2 | – | Sell |
-51,800
| Closed | -$18.6K | – | 57 |
|
|
2023
Q1 | $18.6K | Sell |
51,800
-11,400
| -18% | -$4.1K | ﹤0.01% | 57 |
|
|
2022
Q4 | $56K | Hold |
63,200
| – | – | 0.01% | 50 |
|
|
2022
Q3 | $99K | Hold |
63,200
| – | – | 0.16% | 54 |
|
|
2022
Q2 | $174K | Hold |
63,200
| – | – | 0.02% | 54 |
|
|
2022
Q1 | $119K | Hold |
63,200
| – | – | 0.17% | 67 |
|
|
2021
Q4 | $294K | Buy |
+63,200
| New | +$294K | 0.02% | 64 |
|